Sophia Antipolis, May 6, 2021: One in four heart attack patients have atypical symptoms such as breathing difficulties, extreme exhaustion, and abdominal pain,...
Sophia Antipolis, April 16, 2021: Working hours that deviate from an individual’s natural body clock are associated with greater cardiovascular risk, according...
Sophia Antipolis, February 4, 2021 — Emergency heart attack treatment is effective in patients with cancer, yet many do not receive it.
DALLAS, Nov. 17, 2020 -- The investigational medication finerenone reduced the risk of heart attack, stroke, heart failure and other negative cardiovascular events...
November 16, 2020 — The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol—the so-called “bad” cholesterol—by 50 percent in patients...
DALLAS, Nov. 16, 2020 -- A one-month treatment of dual anti-platelet therapy is safe and as effective as a longer duration of therapy at preventing cardiac...
November 13, 2020 — The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according...
Test could inform d